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Background: Silencing mammalian genes by targeted DNA (cytosine-5) methylation of selected CG sites in the
genome would be a powerful technique to analyze epigenomic information and to study the roles of DNA
methylation in physiological and pathological states. A promising approach of targeted DNA methylation is based
on the ability of split fragments of a monomeric DNA methyltransferase (C5-MTase) to associate and form active
enzyme. A few C5-MTases of different specificities have been shown to possess the ability of fragment
complementation, but a demonstration of this phenomenon for a C5-MTase, which has CG specificity and thus can
be targeted to methylate any CG site, has been lacking. The purpose of this study was to test whether the
CG-specific prokaryotic C5-MTase M.SssI shows the phenomenon of fragment complementation.
Results: We show that truncated inactive N-terminal fragments of M.SssI can assemble with truncated inactive
C-terminal fragments to form active enzyme in vivo when produced in the same E. coli cell. Overlapping and
non-overlapping fragments as well as fragments containing short appended foreign sequences had
complementation capacity. In optimal combinations C-terminal fragments started between conserved motif VIII and
the predicted target recognizing domain of M.SssI. DNA methyltransferase activity in crude extracts of cells with the
best complementing fragment pairs was ~ 4 per cent of the activity of cells producing the full length enzyme.
Fusions of two N-terminal and two C-terminal fragments to 21.6 kDa zinc finger domains only slightly reduced
complementation ability of the fragments.
Conclusions: The CG-specific DNA methyltransferase M.SssI shows the phenomenon of fragment complementation
in vivo in E. coli. Fusion of the split fragments to six unit zinc finger domains does not substantially interfere with
the formation of active enzyme. These observations and the large number of complementing fragment
combinations representing a wide range of MTase activity offer the possibility to develop M.SssI into a
programmable DNA methyltransferase of high specificity.
Keywords: SssI DNA methyltransferase, DNA methylation, 5-methylcytosine, Protein fragment complementation,
Protein fusion, Zinc fingerBackground
Cytosine C5-methylation plays important roles in several
biological phenomena, such as restriction-modification
in prokaryotes, genomic imprinting and carcinogenesis
in eukaryotes [1]. This reaction is catalyzed by DNA
(cytosine-5) methyltransferases (C5-MTase), which
transfer a methyl group from S-adenosyl-methionine
(AdoMet) to carbon 5 of cytosine in specific DNA
sequences [2]. Prokaryotic C5-MTases contain ten* Correspondence: kiss.antal@brc.mta.hu
Institute of Biochemistry, Biological Research Center of the Hungarian
Academy of Sciences, Temesvári krt. 62, 6726 Szeged, Hungary
© 2012 Slaska-Kiss et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumconserved sequence motifs and a so-called variable re-
gion located between conserved motifs VIII and IX [3].
The conserved motifs are responsible for the general
steps of the methyl transfer reaction [4-9], whereas spe-
cific sequence recognition is mediated mainly by the
variable region [10] [11]. Our understanding of the
three-dimensional structure of C5-MTases and of their
interaction with substrate DNA is mainly based on the
X-ray structures of two enzymes: M.HhaI and M.HaeIII.
They revealed that both MTases fold in two domains,
the large domain encompassing most of the conserved
motifs and the small domain containing the variable re-
gion and conserved motif IX. The two domains form atral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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facing the small domain and the minor groove facing the
large domain. All specific DNA-protein interactions are
at the small domain – major groove interface [12,13].
Eukaryotic C5-MTases are larger proteins but the se-
quence homology they share with prokaryotic C5-
MTases and the available biochemical data suggest that
they have the same catalytic mechanism [14,15].
Although the vast majority of characterized C5-
MTases function as monomers, there are exceptions: M.
AquI (CYCGRG) and M.EcoHK31I (YGGCCR) consist
of two polypeptides. The larger subunit of M.AquI con-
tains conserved motifs I – VIII and part of the variable
region, whereas the smaller subunit contains the distal
half of the variable region and conserved motifs IX - X
[16,17]. In M.EcoHK31I, the larger subunit encompasses
conserved motifs I – VIII, X as well as the predicted tar-
get recognition domain (TRD), and only motif IX is
located in the smaller polypeptide [18]. The structural
plasticity of C5-MTases is also supported by the
phenomenon of protein fragment complementation
observed with three enzymes: N- and C-terminal in-
active fragments of three naturally monomeric C5-
MTases (M.BspRI, M.BsuRI and M.HhaI) can assemble
to form active MTase if expressed in the same E. coli
cell, [19,20].
The goal of this work was to test whether M.SssI,
which has the same specificity (CG) as the eukaryotic
DNA MTases [21] and therefore has special importance
as an experimental tool in the study of eukaryotic DNA
methylation, is capable of fragment complementation. In
higher eukaryotes, DNA methylation occurs at CG dinu-
cleotides (CpG sites) and is associated with gene silen-
cing [22]. Targeted DNA methylation, i.e. selective
methylation of predetermined CpG sites in the genome
is emerging as a promising technique for selective gene
silencing [23-27]. The applicability of targeted methyla-
tion as a research tool or as a potential therapeutic ap-
proach critically depends on the specificity of targeting,
i. e. on the difference of methylation between targeted
and non-targeted sites. One approach to increase target-
ing specificity capitalized on the phenomenon of func-
tional complementation between inactive fragments of
the MTase. In the first implementation of this technique
complementing N- and C-terminal fragments of the
HhaI MTase were genetically fused to zinc finger pro-
teins (ZFP) engineered to recognize different nine bp
sequences. When the MTase fragment-ZFP fusion pro-
teins were expressed in the same E. coli cell, the targeted
M.HhaI recognition site, which was flanked by the two
closely spaced ZFP binding sites, became methylated,
whereas the other M.HhaI recognition sites on the same
plasmid stayed unmethylated [28]. Although this strategy
is likely to require improvement to suppress the non-targeted background methylation mainly deriving from
the reconstitution of the MTase in unbound state [29], it
probably remains the most promising approach for
achieving the specificity required for using targeted
methylation as a reliable research tool [30,31]. However,
of the C5-MTases shown to possess the capacity of frag-
ment complementation, only M.HhaI can be used to tar-
get CpG sites, and even M.HhaI can methylate only a
small subset of CpG sites (1 in 16, those in GCGC con-
text). To be able to target any CpG site, one needs a C5-
MTase with CG specificity such as M.SssI.
Here, we report that M.SssI shows the phenomenon of
fragment complementation, thus it is, in principle, suit-
able for the split fragment approach of targeted DNA
methylation.
Results
Construction of plasmids expressing truncated fragments
of M.SssI
M.SssI consists of 386 amino acids and contains all con-
served sequence motifs typical for C5-MTases [21]
(Figure 1). There is no X-ray structure available for M.
SssI, but a computational model has been created using
previously solved structures of the HhaI and HaeIII
MTases [32]. According to this model, M.SssI has the
same global architecture as M.HhaI and M.HaeIII, it
consists of a large domain comprising conserved motifs
I-VIII and X, and a small domain containing conserved
motif IX and the TRD. The function of several residues
predicted by sequence homology and the computational
model was tested by mutational analysis [8].
To test complementation between split fragments of
M.SssI in vivo, the gene segments encoding N-terminal
fragments were cloned in pBAD24 (ApR), whereas the
gene segments coding for C-terminal fragments were
cloned in the compatible plasmid vector pOK-BAD
(KnR). In both vectors transcription of the target gene is
under the control of the araBAD promoter and the
AraC protein, expression can be induced by arabinose
and repressed by glucose [34,35]. Placing the genes of
the N- and C-terminal fragments under the same tran-
scriptional control allowed coordinated expression of the
two fragments. For future applications, almost all frag-
ments were designed to carry N- or C-terminal 6xHis-
tag. Because one of our aims was to explore possibilities
of chemical coupling of the MTase to triplex forming
oligonucleotides [36], the C-terminal His-tag was engi-
neered to carry a cysteine as the last amino acid
(Table 1).
Functional complementation between inactive fragments
of M.SssI in vivo
First two plasmids (pB-Sss[1–189] and pBNH-Sss[1–
304]) expressing N-terminal, and four plasmids (pOB-
Figure 1 CLUSTAL W sequence alignment [33] between M.SssI and M.HhaI. Conserved motifs [2,3,8] are underlined and marked by Roman
numerals. The TRD of M.HhaI [12] is in italics. The ends of N-terminal fragments constructed in this study are marked by bent symbols and the
beginnings of C-terminal fragments by arrowheads above the sequence. C-terminal fragments displaying good, medium or no complementation
of the [1–304] fragment are indicated by black, grey and empty arrowheads, respectively.
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pOB-Sss[304–386]) expressing C-terminal polypeptides
were constructed. (Figure 2 and Table 1, the numbers in
square brackets indicate the first and the last amino acid
of the M.SssI fragment encoded by the plasmid.) Some
of the break points were selected to approximately
match the ends or the beginnings of fragments of the
other C5-MTases, for which the phenomenon of frag-
ment complementation has been demonstrated [19]
[20]. Plasmids coding for N- or C-terminal fragments
were introduced individually or pairwise into E.coli
DH10B. The recA host was used in these experiments to
minimize the possibility of recombination between hom-
ologous segments of the two plasmids. Transformants
were grown in the absence or presence of the inducer
arabinose overnight. Methylation status of plasmid DNA
isolated from the cultures was tested by digestion with
the GCGC-specific restriction endonuclease Hin6Iwhose activity is blocked by M.SssI-specific methylation.
The vectors pBAD24 and pOK-BAD contain 32 and 21
Hin6I sites, respectively.
As expected, all plasmids purified from single-
transformants were fully digestible with Hin6I, indicat-
ing that the truncated fragments were inactive. Simi-
larly, the plasmids purified from double-transformants
expressing the fragment pairs [1–189] + [191–386] or
[1–304] + [304–386] were completely digestible. However,
plasmid preparations purified from the arabinose-induced
cultures of the double-transformants containing pBNH-
Sss[1–304] plus pOB-Sss[191–386] or pOB-Sss[241–386]
were partially protected against Hin6I digestion (Fig-
ure 3). This suggested that the N-terminal fragment
[1–304] could assemble with the [191–386] or the
[241–386] C-terminal fragment to reconstitute the active
MTase. The [1–304] + [279–386] combination gave barely
detectable protection (not shown). No protection was
Table 1 Plasmids encoding N- or C-terminal fragments of M.SssI
Plasmid Res. N-terminal extension1 C-terminal extension1
pB-Sss[1–189] Ap EI
pBNH-Sss[1–176] Ap MVPGMH6LEC KLGCFGG
pBNH-Sss[1–222] Ap MVPGMH6LEC ASLAVLADERRFSA
pBNH-Sss[1–239] Ap MVPGMH6LEC SCFGG
pBNH-Sss[1–248] Ap MVPGMH6LEC LAVLADERRFSA
pBNH-Sss[1–257] Ap MVPGMH6LEC EAWLFWRMREDFQPDTD
pBNH-Sss[1–304] Ap MVPGMH6LEC
pBNH-Sss[1–317] Ap MVPGMH6LEC KLGCFGG
pBNH-Sss[1–318] Ap MVPGMH6LEC KLGCFGG
pBNH-Sss[1–324] Ap MVPGMH6LEC LGCFGG
pBNH-Sss[1–356] Ap MVPGMH6LEC KLGCFGG
pB6ZB-Sss[1–239] Ap 6-ZFP-B zinc finger domain SCFGG
pB6ZB-Sss[1–304] Ap 6-ZFP-B zinc finger domain
pOB-Sss[191–386] Kn MVP SH6C
pOB-Sss[231–386] Kn MVP SH6C
pOB-Sss[240–386] Kn MV SH6C
pOB-Sss[241–386] Kn M SH6C
pOB-Sss[242–386] Kn MVQ SH6C
pOB-Sss[246–386] Kn MV SH6C
pOB-Sss[250–386] Kn MVH SH6C
pOB-Sss[254–386] Kn MVP SH6C
pOB-Sss[261–386] Kn MV SH6C
pOB-Sss[279–386] Kn M SH6C
pOB-Sss[304–386] Kn M SH6C
pOB-Sss[316–386] Kn MVP SH6C
pOB-Sss[321–386] Kn MVP SH6C
pSss[191–386]del2 Kn MVP SH6C
pSss[241–386]del2 Kn M SH6C
pOB-Sss[191–386]SS Kn SH6C
pOB-Sss[241–386]-6ZA Kn M 6-ZFP-A zinc finger domain
pOB-Sss[261–386]-6ZA Kn MV 6-ZFP-A zinc finger domain
pBS-CAL75 Ap
pBS-Sss6ZA Ap 6-ZFP-A zinc finger domain
Numbers in square brackets specify the M.SssI fragment expressed by the plasmid.
1 N- and C-terminal extensions were added on purpose (His tag) or are byproducts of the cloning procedure. 2Plasmid lacking the PBAD promoter.
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and complementation was more efficient at 30 °C than
at 37 °C.
Since the truncated genes of the complementing N-
and C-terminal polypeptides contained overlapping seg-
ments, it was important to exclude the possibility that
MTase activity arose by reconstitution of the intact
MTase gene via homologous recombination. To test this,
the araBAD promoter and part of the araC gene was
deleted from pOB-Sss[191–386] and pOB-Sss[241–386]
leaving the [191–386] and [241–386] coding sequenceintact. The resulting plasmids (pSss[191–386]del and
pSss[241–386]del) did not complement pBNH-Sss[1–
304] (not shown) indicating that for restoration of MTase
activity synthesis of the C-terminal peptide was required,
and a recombination mechanism can be excluded.
To determine the optimal C-terminal fragment length
for complementation, nested deletions were generated
by exonuclease III digestion starting from the N-
terminus of the [191–386] fragment as described in
Methods. The obtained plasmids encoding the truncated






















































Figure 2 Schematic map of the relevant regions of some plasmids used in this study. Blue horizontal bar, sssIM gene coding sequence;
gray horizontal bar, 6-ZFP-A zinc finger protein gene; red arrow, araBAD promoter. Restriction sites used in plasmid constructions are shown.
Maps are not drawn to scale.
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[321–386] are listed in Table 1. When tested in combin-
ation with pBNH-Sss[1–304], some protection against
Hin6I digestion was detectable for all fragments having
overlaps with fragment [1–304]. The most efficient
methylation was observed with fragments starting at
241, 242 and 246 (Figure 4A). These residues are located
between conserved motif VIII and the assumed TRD of
M.SssI (Figure 1).
In a reciprocal approach, nested deletions were intro-
duced from the 3’-end of the M.SssI gene. Plasmids
expressing the following polypeptides were isolated:
[1–176], [1–222], [1–239], [1–248], [1–257], [1–317],
[1–318], [1–324] and [1–356] (Table 1 and Figure 1).
Because in these plasmids the truncated gene was
fused to vector sequence, translation termination is
determined by the next in-frame stop codon down-
stream of the PaeI site (Figure 2), and the fragments
carry short C-terminal appendages of foreign sequence
(Table 1). These plasmids were tested in combination
with pOB-Sss[241–386] and pOB-Sss[242–386], two of
the plasmids that most efficiently complemented the
N-terminal polypeptide [1–304]. The two shortest frag-
ments ([1–176] and [1–222]) did not complement
[241–386] (Figure 4B). Complementation by fragment[1–239] was rather efficient, whereas only poor methy-
lation activity was observed with fragments [1–248]
and [1–257]. The low complementation capacity of the
latter two fragments is probably due to the relatively
long foreign sequence at their C-terminus (Table 1).
All longer fragments were active in the complementa-
tion test and resulted in comparable levels of methyla-
tion (Figure 4B). Similar results were obtained when
[242–386] was used as C-terminal fragment although
in this combination fragments [1-248/257] appeared
more active than with [241–386] (Figure 4C vs. 4B). The
complementation observed with the [1–239] + [241/
242-386] pairs is noteworthy because in these cases
there is no overlap between the fragments.
It has been observed in several systems that sequence
overlap between the fragment pairs was beneficial or
even essential for complementation [20,37,38]. To test
this requirement for M.SssI in more detail, a series of C-
terminal fragments were tested in combination with [1–
239]. Fragments [240/241/242-386] were highly active in
pair with [1–239], whereas the few residues shorter
[246–386] fragment was already ineffective (Figure 4D).
It was shown before that the [1–189] + [191–386] and
the [1–304] + [304–386] combinations were inactive (see







































































- + - + - + + + + +
M
Figure 3 Functional complementation between inactive
fragments of M.SssI. Hin6I digestion of plasmids expressing the M.
SssI fragments shown above the lanes. Protection against Hin6I
digestion is a sign of C5-methylation at CG sites. Plasmids indicated
by underlining were prepared from cells grown in the presence of
0.5 % arabinose. M, DNA size marker (Fermentas). Undigested and
digested samples are identified by – and+ signs, respectively below
the lanes.
Ślaska-Kiss et al. BMC Molecular Biology 2012, 13:17 Page 6 of 12
http://www.biomedcentral.com/1471-2199/13/17[191–386] were active in combination with fragment(s),
which they overlapped, these observations show that the
requirement for overlap depends on the location of
the break. If the bisection point is in the proximal half
of the variable region, no overlap is required, and even
the loss of a few amino acids can be compatible with
MTase activity. In contrast, if the bisection point is in
regions less optimal for fitting the two polypeptides to-
gether, a short overlap between the fragment pairs appears
to be necessary for the formation of the active complex.
To test how M.SssI tolerates splits in more distal parts
of the variable region, plasmids producing different N-
terminal fragments were tested in combination with
pOB-Sss[279–386] and pOB-Sss[304–386]. Methylation
of the plasmid pairs expressing fragments [1-304/317/
324] + [279–386] was hardly detectable, and no methyla-
tion was detected with the [1-317/318/324] + [304–386]
combinations (not shown). These results and the previ-
ous observation that the [1–304] + [304–386] pair was
inactive (see above) suggest that for efficient comple-
mentation the small domain must be intact. A summary
of the complementation properties of M.SssI fragments
generated and studied in this work is in Figure 5.To compare M.SssI activities in vivo between repre-
sentatives of the best complementing fragment pairs and
intact M.SssI, extracts were prepared from arabinose
induced cells and MTase activity was determined using
radioactively labeled AdoMet as described in Methods.
The following MTase activities (derived from three inde-
pendent experiments and expressed in cpm/μg extract
protein) were obtained (with the enzyme in parentheses):
1016 ± 369 (full-length), 16 ± 0 ([1–304]), 53 ± 14 ([1–
304] + [242–386]) and 65 ± 8 ([1–304] + [246–386]). As-
suming similar levels of expression, these values suggest
that the activities of even the best complementing pairs
is below 5 per cent of that of the intact enzyme.
In the envisaged approach of targeted methylation, tar-
geting is achieved by zinc finger proteins fused to the
MTase halves [28]. Statistically, a 16 bp sequence occurs
once in the human genome. Thus, for the intended spe-
cificity, a 18 bp zinc finger binding site should be suffi-
ciently long as has been demonstrated [39]. Therefore,
for testing whether fusion of the M.SssI fragments to
zinc finger proteins could impair their complementation
ability, we chose six-finger proteins that recognize 18 bp
sequences. Two N- and two C-terminal M.SssI frag-
ments ([1–239], [1–304], [241–386] and [261–386])
were genetically fused to the zinc finger domains 6-ZFP-
A and 6-ZFP-B described in [40]. The 6-ZFP-B domain
was fused to the amino end of the N-terminal fragments,
whereas the 6-ZFP-A domain was fused to the carboxy
end of the C-terminal fragments to yield pB6ZB-Sss[1–
239], pB6ZB-Sss[1–304], pOB-Sss[241–386]-6ZA and
pOB-Sss[261–386]-6ZA (Table 1). Fusions to ZFPs
slightly decreased complementation capacity in all tested
cases (Figure 6 vs. Figure 4), but with the two better
combinations substantial activity remained and even for
the fragment pair displaying the lowest activity ([1–
304] + [261–386], Figure 4A) appending the ZFPs did
not fully abolish MTase activity (Figure 6).
Discussion
In this study we identified N- and C-terminal fragments
of the SssI MTase, which can assemble with a counter-
part fragment to form active MTase when produced in
the same E. coli cell. All available evidence supports the
conclusion that the observed phenomenon is indeed
peptide complementation and not the result of DNA re-
combination restoring the intact MTase gene. Firstly, de-
letion of the promoter of two C-terminal fragments
abolished complementation (see above). Secondly, plas-
mid pairs with longer overlaps between the 5’- and 3’
gene segments were not necessarily more efficient in
complementation than fragments with shorter overlaps
(Figure 4A). Thirdly, in the experiment in which the
[191–386] fragment was shortened from the N-terminus





























































































































































































Figure 4 Dependence of complementation efficiency on fragment length and overlap. Hin6I digestion of plasmids expressing the M.SssI
fragments shown above the lanes (the first sample on panel A was not digested). Plasmids were purified from cultures grown in the presence of
0.05 % arabinose. Protection against Hin6I digestion is a sign of C5-methylation at CG sites.
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stantial overlap with the gene of the [1–304] fragment
but fused to the ATG initiation codon in incorrect read-
ing frame. When these plasmids were co-transformed
with pBNH-Sss[1–304], methylation was not detectable,
confirming that M.SssI activity required synthesis of the
C-terminal peptide (not shown). Finally, complementa-
tion observed between some plasmids containing non-overlapping gene segments such as [1–239] + [241/242-
386] (Figures 4D) also argues against the recombination
model.
Although a large number of fragment pairs resulted in
detectable M.SssI activity, the most efficient methylation
was observed with fragment combinations involving C-
terminal fragments starting between conserved motif
VIII and the assumed TRD, with a sharp optimum
Figure 5 In vivo complementation between M.SssI fragments. Some of the fragments carry N- or C-terminal appendages (see Table 1). The
approximate level of plasmid methylation as determined by restriction protection assay is indicated by + signs, and the lack of methylation
by – sign. Boxes for untested combinations were left empty.
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of an X-ray structure it is difficult to rationalize these
results but the location of split sites in the region con-
necting the predicted large and small domains [32]
would be consistent with the general principle that frag-
ment complementation is most efficient between folded
units [37]. The flexible random coil conformation pre-
dicted for the segment Glu241 - Ile262 [32] could also










Figure 6 Complementation between inactive M.SssI fragments
fused to zinc finger domains. DH10B cells contained pB6ZB-Sss
[1–304], pB6ZB-Sss[1–239], pOB-Sss[241–386] or pOB-Sss[261–386]
in combinations indicated by the names of the encoded fusion
proteins above the lanes. Plasmids were purified from cultures
grown in the absence or presence of 0.05 % arabinose. Lanes 1,
undigested plasmid; lanes 2, uninduced and Hin6I-digested; lanes
3, induced and Hin6I-digested. M, DNA marker.is noteworthy that the beginning (K210) of the C-ter-
minal M.HhaI fragment producing complementation
was in the same region, between motif VIII and the TRD
[20].
Evaluation of the phenotypes of the N-terminal frag-
ments generated by exonuclease III digestion is less
straightforward because the extraneous C-terminal pep-
tides appended by the cloning procedure (Table 1) are
likely to interfere with assembly of the subunits. In con-
trast to the C-terminal fragments, the complementation
ability of the N-terminal fragments did not show a clear
optimum. All overlapping fragments, which did not have
longer extraneous C-terminal peptide could complement
fragments [241–386] and [242–386] and the comple-
mentation capacity of these fragments appeared to be
similar (Figures 4 B and C).
This work was motivated by the desire to develop M.
SssI into a programmable DNA MTase suitable to
methylate unique CpG sites in the genome. Here, as a
first step toward this goal, the ability of M.SssI for frag-
ment complementation has been demonstrated and frag-
ment combinations displaying different levels of MTase
activity in vivo have been identified. These results open
the possibility for developing a system for targetable
CpG methylation using the split fragment approach,
which will involve construction of fusions between frag-
ments of M.SssI and appropriately designed ZFP target-
ing domains. The split fragment approach is in many
ways reminiscent of the technique using ZFP-FokI
chimeric nucleases for targeted DNA cleavage [41]. Low
activity of the heterodimers can be an advantage for in-
creasing targeting specificity especially if it derives from
the low affinity between the MTase halves [31]. Ideally,
the split MTase fragments should not be able to
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should form active heterodimers due to increased local
concentration when co-localized to the target site via
the ZFP domains. The best strategy to create a site spe-
cific MTase could be to start with fragments, which can-
not associate into active MTase as has been suggested
[29]. The level of targeting specificity required for
methylation of unique sites in the genome will probably
need extensive optimization of different parameters gov-
erning targetable methylation specificity, such as affinity
to target and non-target DNA, affinity between the
MTase subunits, distance between the ZFP binding site
and the targeted CG, etc.. The large number of comple-
menting fragment combinations representing a wide
range of MTase activity will be a rich source of starting
material to engineer ZFP-M.SssI fusions for programmable
DNA methylation.
Conclusions
The CG-specific M.SssI, similarly to three other natur-
ally monomeric C5-MTases of different specificity,
shows the phenomenon of fragment complementation
in vivo in E. coli. Fusion of the split fragments to six unit
zinc finger domains only slightly decreases the efficiency
of complementation. These observations offer the possi-
bility to develop M.SssI into a programmable DNA
methyltransferase of high specificity that can be useful
in the study of DNA methylation in higher eukaryotes.
Methods
Strains and growth conditions
The Escherichia coli strain DH10B F− endA1 recA1
galE15 galK16 nupG rpsL ΔlacX74 80dlacZΔM15
araD139 Δ(ara leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC)
relA1 spoT1 λ− [42] was used as general cloning host
and CJ236 FΔ(HindIII)::cat (Tra+ Pil+ CamR)/ung-1
relA1 dut-1 thi-1 spoT1 mcrA as host for site-directed
mutagenesis.
Cells were grown in LB medium at 30 or 37 °C. Ampi-
cillin (Ap) and kanamycin (Kn) were used at 100 and
50 μg/ml, respectively. L-arabinose (Sigma) was used at
0.5-0.005 % as indicated at the experiments.
Plasmids
pBAD24 is an expression vector plasmid, in which tran-
scription of the target gene is tightly controlled by the
araBAD promoter and the AraC protein [34]. pOK-
BAD, a Kn-resistant derivative of pBAD24, has p15A
replicon, thus is compatible with ColE1-based plasmids
such as pBAD24 [35].
All variants of the sssIM gene described in this paper
are derived from the allele in the plasmid pCAL7
obtained from New England Biolabs. The sssIM allele in
pCAL7, considered as the WT allele for this work,carries mutations that change four TGA stop codons,
which normally specify Trp in the native host Spiro-
plasma sp., to TGG (W. Jack, personal communication).
The pBAD24-based plasmids pB-MSssI and pBNH-
MSssI encode the WT and an N-terminally His-tagged
M.SssI variant, respectively (Figure 2).
Plasmids encoding N-terminal M.SssI fragments are
based on the vector pBAD24, and have names starting
with pB, whereas plasmids that encode C-terminal M.
SssI fragments, are based on the vector pOK-BAD and
carry names starting with pOB- (Table 1).
Plasmid pB-Sss[1–189] was constructed by deleting
the Ecl136II – SmiI fragment of pB-MSssI (Figure 2).
Ecl136II cuts after the codons of the conserved E186NV
motif and SmiI after the stop codon. This deletion cre-
ated a reading frame ending two triplets downstream of
the Gly189 codon. Thus, the MTase fragment encoded by
pB-Sss[1–189] carries a two amino acid C-terminal ap-
pendage ENVGEI (underlined).
pBNH-Sss[1–304] is a derivative of pBNH-MSssI, and
encodes the [1–304] fragment of M.SssI. To construct
pBNH-Sss[1–304], the M.SssI gene segment correspond-
ing to the peptide A190 – V304 was PCR-amplified using
the primers AK183 and AK184. AK183 contains the
Ecl136II (SacI) site located in the middle of the SssI
gene. AK184 introduced a stop codon and a PstI site
after the triplet corresponding to Val304 (Table 2). The
PCR-product was T/A-cloned in pTZ57R/T (Fermentas),
then excised by SacI–PstI double digestion and trans-





and pBNH-Sss[1–356] are deletion derivatives of pBNH-
MSssI and were generated by exonuclease III digestion.
pBNH-MSssI was digested with Bpu1102I and PaeI,
which have single sites in the plasmid downstream of
the M.SssI gene (Figure 2). Unidirectional deletions
starting from the Bpu1102I end (5’-overhang) were made
by exonuclease III [43]. The 3’-overhang of the PaeI end
protected the downstream sequences. The M.SssI frag-
ments expressed from the plasmids obtained by exo-
nuclease digestion carry short C-terminal appendages
(Table 1) determined by the fused vector sequence
downstream of the PaeI site.
Plasmids pOB-Sss[191–386], pOB-Sss[241–386], pOB-
Sss[279–386] and pOB-Sss[304–386] are based on the
expression vector pOK-BAD and encode C-terminal M.
SssI fragments. They were constructed either by direct
fragment transfer or PCR amplification from a plasmid
expressing a C-terminally His-tagged M.SssI variant.
This variant and the derived C-terminal polypeptides
used in this work carry a cysteine at the end of the His-
Table 2 Deoxyoligonucleotides used in this work
Name Sequence Properties1 Use
AK183 GAGCTCTTCTTCACAAGAAGA M.SssI gene sense strand,
positions 566-586. Starts
with a SacI site
Forward primer for
[190-304]
AK184 GCTGCAGTTAAACATAACCTTCTGAATT M.SssI gene anti-sense
strand, positions 912-895,
stop codon and PstI site added
Reverse primer for
[1-304]
AK185 GCCATGGAATTTAAAAAAACAAAATCA M.SssI gene sense strand,




AK186 GCTGCAGTTAGCAGTGATGGTG M.SssI gene anti-sense





AK188 GCCATGGTTTATGATCCTGAATTTACA M.SssI gene sense strand,




AK189 GCCATGGAATTTGTTGAACTACCAAAG M.SssI gene sense strand,




AK258 GGCACGCTGACTAAAGGATTTACCGCACTCGGG 6-ZFP-A gene antisense
strand
Mutagenic primer
for elimination of a
HindIII site
AK259 GCAGCTGTTTCTCCAAAGAAGAAGAGAAAAGT Forward primer for
amplification of
the 6-ZFP-A gene
AK260 GCTGCAGTTAACCCAGCTCGCCG Reverse primer for
amplification of
the 6-ZFP-A gene
Sequences are written in 5’ to 3’ direction. Sequences, which do not correspond to the template DNA, are underlined. 1Nucleotide positions are calculated relative
to the first nucleotide of the ATG start codon of the WT M.SssI gene.
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relevant to the present study, was added for future appli-
cations.) Plasmid pOB-Sss[191–386] was constructed by
cloning the Ecl136II-PstI fragment encoding the His-
tagged [191–386] polypeptide between the filled-in
Acc65I site and the PstI site in the pOK-BAD polylinker.
The variant encoded by pOB-Sss[191–386] has the fol-
lowing N-terminal sequence MVPL191LHKK. The
underlined three amino acid extension is encoded by the
pOK-BAD polylinker. To construct plasmids expressing
the [241–386], [279–386] and [304–386] polypeptides,
the respective gene segments were PCR-amplified using
AK189, AK185 or AK188 as forward primer and AK186
as reverse primer (Table 2). In pOK-BAD the NcoI site
overlaps the translational start codon. To facilitate clon-
ing of the synthesized fragments in pOK-BAD, the for-
ward primers were designed to carry a 5’-extension with
an NcoI site. The amplified fragments were inserted be-
tween the NcoI and PstI sites of pOK-BAD.
Plasmids pSss[191–386]del and pSss[241–386]del were
made by deleting the BssHII–NcoI fragment of pOB-Sss
[191–386] and pOB-Sss[241–386], respectively. BssHII
cuts in the middle of the araC gene and the NcoI site
contains the ATG start codon of the truncated MTase
genes (Figure 2). Thus, this deletion removes part of thearaC gene along with the araBAD promoter and transla-
tional initiation signals for the [191–386] and [241–386]
polypeptides.
Plasmids pOB-Sss[231–386], pOB-Sss[240–386], pOB-
Sss[242–386], pOB-Sss[246–386], pOB-Sss[250–386],
pOB-Sss[254–386], pOB-Sss[261–386], pOB-Sss[316–386]
and pOB-Sss[321–386] are deletion derivatives of
pOB-Sss[191–386] and were obtained by exonuclease III
digestion. To have appropriate restriction sites for uni-
directional exonuclease III treatment, pUC18 linearized
with KpnI was inserted into the unique KpnI site of
pOB-Sss[191–386] located in the gene section coding
for the N-terminal MVP appendage (see above) i.e. be-
tween the start codon and the gene segment encoding
the [191–386] fragment. A plasmid, in which the orien-
tation of pUC18 was such that the unique SacI site was
upstream (towards the translational start codon),
whereas the unique SalI site was downstream, was
chosen for further work. Part of the inserted pUC18,
which was not needed for controlling the exonuclease
III digestion, was deleted by ApaLI digestion and
circularization of the large fragment to yield pOB-Sss
[191–386]SS (Figure 2). To generate random 5’-deletions
in the gene of the [191–386] fragment, pOB-Sss[191–
386]SS was cut with SalI (5’-overhang) and SacI (3’-
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above. The SalI end allowed exonuclease III digestion to
start whereas the SacI end protected upstream
sequences, such as the PBAD promoter and the initiation
codon. As byproducts of the cloning steps, some of the
M.SssI fragments encoded by these plasmids carry short
N-terminal extensions (Table 1).
The plasmids pcDNA3.1mnhk-up1 and pcDNA3.1mnhk-
up2 encode the zinc finger proteins 6-ZFP-A and 6-ZFP-B,
respectively [40], and were kindly provided by M. Rots. To
construct fusions between the N-terminal M.SssI fragments
[1–304], [1–239] and 6-ZFP-B, the 6-ZFP-B coding region
was transferred, on an NcoI-XhoI fragment, from
pcDNA3.1mnhk-up2, into pBNH-Sss[1–304] and pBNH-
Sss[1–239] to yield pB6ZB-Sss[1–304] and pB6ZB-Sss[1–
239], respectively. For fusions to C-terminal M.SssI frag-
ments, the HindIII site in the 6-ZFP-A zinc finger gene was
eliminated by site directed mutagenesis using the muta-
genic primer AK258. The resulting 6-ZFP-A gene carrying
the silent mutation was PCR-amplified using primers
AK259 and AK260 containing PvuII and PstI sites as 5’-
extensions, respectively (Table 2). The PCR product was T/
A-cloned in pTZ57R/T, then excised by PvuII - PstI
double-digestion and cloned between the HpaI and PstI
sites of pBS-CAL75, a plasmid containing the 3’-half of the
sssIM gene with an engineered HpaI site overlapping the
M.SssI stop codon (Figure 2). Ligation of the PvuII end of
the PCR fragment to the HpaI end of pBS-CAL75 creates
in-frame fusion between the MTase and the 6-ZFP-A zinc
finger domain (Figure 2, plasmid pBS-Sss6ZA). C-terminal
fusions between the M.SssI fragments [241–386]/[261–386]
and 6-ZFP-A were constructed by inserting the HindIII
fragment of pBS-Sss6ZA containing the 3’-end of the M.
SssI gene and the coding sequence of 6-ZFP-A (Figure 2)
into the unique HindIII site located in the 3’ half of the M.
SssI coding sequence (Figure 2) in pOB-Sss[241–386] and
pOB-Sss[261–386] to yield pOB-Sss[241–386]-6ZA and
pOB-Sss[261–386]-6ZA, respectively.
Nucleotide sequences of the plasmids are available
upon request.
DNA techniques
Restriction digestion, polymerase chain reaction, agarose
gel electrophoresis and cloning in E. coli plasmid vectors
was carried out using standard procedures [43]. Oligo-
nucleotides were purchased from IDT or were synthe-
sized in this institute and are listed in Table 2.
Restriction endonucleases, DNA polymerase large (Kle-
now) fragment, Taq DNA polymerase, exonuclease III,
S1 nuclease and T4 DNA ligase were purchased from
Fermentas or New England Biolabs. Site-directed muta-
genesis was performed by the Kunkel method [44]. Uni-
directional deletions were generated by the combined
use of exonuclease III, S1 nuclease, Klenow DNApolymerase and T4 DNA ligase [43]. DNA sequence was
determined by an automated sequencer (ABI).
Methyltransferase assay in crude extracts
E. coli cells with plasmids encoding M.SssI fragment(s)
or the full-length enzyme were grown at 37 °C to
OD550 ~ 0.5, then 0.1 % arabinose was added and cultur-
ing was continued for 3 hrs at 30 °C. Cells sedimented
from 200 ml culture by centrifugation were resuspended
in 0.2 ml 50 mM Tris–HCl pH 8.0, 10 mM 2-mercap-
toethanol and disrupted by sonication. After removing
cell debris by centrifugation, M.SssI activity was deter-
mined in 30 μl reactions containing 0.9 μg lambda phage
DNA (dam-, dcm-), 50 mM Tris–HCl pH 8.5, 50 mM
NaCl, 10 mM EDTA, 5 mM DTT, 5 μM [methyl-3H]
AdoMet and 2 μl cell extract. The [methyl-3H]AdoMet
used in the reaction was prepared by diluting the
370 GBq/mmol preparation (NET155, New England Nu-
clear) to 116 GBq/mmol with unlabeled AdoMet (New
England Biolabs). After incubation at 30 °C for 20 min,
reactions were stopped by 1 % SDS, then the incorpo-
rated radioactivity was determined as described [45].
Protein concentration was determined by the Bradford
reaction (Sigma). MTase activity was calculated by divid-
ing the cpm values by the amount of total protein in
2 μl cell extract (in μg) used in the assay.
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